These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
455 related articles for article (PubMed ID: 15294884)
1. Oxidative stress in the pathogenesis of diabetic neuropathy. Vincent AM; Russell JW; Low P; Feldman EL Endocr Rev; 2004 Aug; 25(4):612-28. PubMed ID: 15294884 [TBL] [Abstract][Full Text] [Related]
2. Diabetic neuropathy and oxidative stress. Pop-Busui R; Sima A; Stevens M Diabetes Metab Res Rev; 2006; 22(4):257-73. PubMed ID: 16506271 [TBL] [Abstract][Full Text] [Related]
3. Diabetic peripheral neuropathy: current perspective and future directions. Singh R; Kishore L; Kaur N Pharmacol Res; 2014 Feb; 80():21-35. PubMed ID: 24373831 [TBL] [Abstract][Full Text] [Related]
4. Glucotoxic Mechanisms and Related Therapeutic Approaches. Yagihashi S Int Rev Neurobiol; 2016; 127():121-49. PubMed ID: 27133148 [TBL] [Abstract][Full Text] [Related]
7. Bradykinin B₁ antagonism inhibits oxidative stress and restores Na+K+ ATPase activity in diabetic rat peripheral nervous system. Catanzaro O; Capponi JA; Michieli J; Labal E; Di Martino I; Sirois P Peptides; 2013 Jun; 44():100-4. PubMed ID: 23528517 [TBL] [Abstract][Full Text] [Related]
8. Protective role of antioxidative food factors in oxidative stress caused by hyperglycemia. Osawa T; Kato Y Ann N Y Acad Sci; 2005 Jun; 1043():440-51. PubMed ID: 16037265 [TBL] [Abstract][Full Text] [Related]
9. Mechanisms of disease: the oxidative stress theory of diabetic neuropathy. Figueroa-Romero C; Sadidi M; Feldman EL Rev Endocr Metab Disord; 2008 Dec; 9(4):301-14. PubMed ID: 18709457 [TBL] [Abstract][Full Text] [Related]
10. Selective susceptibility of different populations of sympathetic neurons to diabetic neuropathy in vivo is reflected by increased vulnerability to oxidative stress in vitro. Semra YK; Wang M; Peat NJ; Smith NC; Shotton HR; Lincoln J Neurosci Lett; 2006 Oct; 407(3):199-204. PubMed ID: 16973273 [TBL] [Abstract][Full Text] [Related]
11. [The pathogenesis of diabetic and hepatic neuropathies]. Winkler G; Kempler P Orv Hetil; 2001 Nov; 142(45):2459-67. PubMed ID: 11778353 [TBL] [Abstract][Full Text] [Related]
12. Polyneuropathy in impaired glucose tolerance: is postprandial hyperglycemia the main culprit? A mini-review. Papanas N; Ziegler D Gerontology; 2013; 59(3):193-8. PubMed ID: 23207896 [TBL] [Abstract][Full Text] [Related]
13. [Diabetic neuropathy: clinical and experimental progress in its pathogenesis and treatment]. Maeda K; Yasuda H Nihon Rinsho; 1999 Mar; 57(3):578-83. PubMed ID: 10199137 [TBL] [Abstract][Full Text] [Related]
14. [Pathogenesis and treatment of diabetic neuropathy]. Grzelec H Neurol Neurochir Pol; 1991; 25(4):477-84. PubMed ID: 1666426 [TBL] [Abstract][Full Text] [Related]
15. Oxidative stress and Nrf2 in the pathophysiology of diabetic neuropathy: old perspective with a new angle. Negi G; Kumar A; Joshi RP; Sharma SS Biochem Biophys Res Commun; 2011 Apr; 408(1):1-5. PubMed ID: 21439933 [TBL] [Abstract][Full Text] [Related]
16. Role of neuropoietic cytokines in development and progression of diabetic polyneuropathy: from glucose metabolism to neurodegeneration. Skundric DS; Lisak RP Exp Diabesity Res; 2003; 4(4):303-12. PubMed ID: 14668051 [TBL] [Abstract][Full Text] [Related]
18. S100B as a glial cell marker in diabetic peripheral neuropathy. Celikbilek A; Akyol L; Sabah S; Tanik N; Adam M; Celikbilek M; Korkmaz M; Yilmaz N Neurosci Lett; 2014 Jan; 558():53-7. PubMed ID: 24211224 [TBL] [Abstract][Full Text] [Related]
19. The role of oxidative stress in diabetic vascular and neural disease. Yorek MA Free Radic Res; 2003 May; 37(5):471-80. PubMed ID: 12797466 [TBL] [Abstract][Full Text] [Related]
20. Can diabetic neuropathy be prevented? Park TS; Park JH; Baek HS Diabetes Res Clin Pract; 2004 Dec; 66 Suppl 1():S53-6. PubMed ID: 15563981 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]